Viewing nowCombinationRotacan Tablet 5/16 Milligrams
Candesartan Cilexetil 16mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Green Cross Corp.

MFDS item code 201803503 · Approved 2018.08.28 · Insurance code 643605570
Treatment of hypertension and heart failure; improvement of dyslipidemia; reduction of the risk of atherosclerosis and cardiovascular disease
This medication is used for patients who need to take two components: Candesartan Cilexetil and Rosuvastatin together. Candesartan Cilexetil is used in patients with essential hypertension and those with heart failure when left ventricular function is impaired, especially when it is necessary to add or replace ACE inhibitors. Meanwhile, Rosuvastatin is prescribed when primary hypercholesterolemia and mixed hyperlipidemia cannot be controlled by diet alone. Additionally, it is used as an adjunct to diet in patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia, helping to slow the progression of atherosclerosis and lower the risk of cardiovascular disease. In high-risk groups with elevated high-sensitivity C-reactive protein levels, it also reduces the risk of stroke, myocardial infarction, and vascular revascularization. Therefore, this medication is used to manage hypertension and hyperlipidemia together to improve cardiovascular health.
This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, candesartan cilexetil and rosuvastatin. ○ Candesartan cilexetil 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Administer an initial dose of 4 mg with particular caution in patients at increased risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks and, based on the patient's tolerability, increase it to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue the diet throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score exceeding 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking candesartan cilexetil and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
○ Candesartan cilexetil — Essential hypertension Safety and efficacy have not been established in adolescents and children 18 years of age or younger. ○ Candesartan cilexetil — Heart failure Safety and efficacy have not been established in adolescents and children 18 years of age or younger.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so its use should be stopped immediately if pregnancy is confirmed. It should not be used by patients who are allergic to this medication or its components, have severely impaired liver function, are pregnant or nursing, or have severe kidney disease. Elderly patients, those with slightly impaired liver function, and patients with hyperkalemia should use this medication with extra caution, and regular liver function tests and blood tests should be done. If symptoms such as muscle pain, weakness, or cramps appear during treatment, contact a doctor immediately, and if necessary, muscle enzyme levels should be checked, and use should be discontinued if abnormalities are found. If liver dysfunction is suspected, use of this medication should be discontinued, and consultation with a doctor is necessary, especially if liver enzyme levels exceed the normal range significantly. This medication can interact with other antihypertensive medications, specific lipid-lowering agents, antibiotics, antifungals, etc., so be sure to inform your doctor or pharmacist of any other medications you are taking. Women who are pregnant or planning to become pregnant should use appropriate contraceptive methods, and those who are nursing should preferably avoid using this medication. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, so you should contact a medical institution immediately for appropriate treatment. Caution is advised during driving or operating machinery as dizziness or fatigue may occur while using this medication. Keep this medication out of the reach of children and do not transfer it from its original container to another.
headache, nasopharyngitis, local infection, fatigue, generalized pruritus, dermatitis, itching, joint stiffness, limb pain, photophobia, dyspepsia, increased blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, headache, itching, nausea, dizziness, orthostatic dizziness, miliaria, periodontal disease, inflammation, foreign body sensation, musculoskeletal pain, neck pain, cataract, increased blood sugar, decreased serum sodium, hand fracture, hypoglycemia, nephrolithiasis, cough, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, angioedema, constipation, abdominal pain, nausea, diarrhea, jaundice, hepatitis, abnormal liver function tests, thrombocytopenia, Stevens-Johnson syndrome, eosinophilia accompanied by systemic symptoms reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, memory loss, peripheral neuropathy, erectile dysfunction, paralysis, tension dysregulation, syncope, facial flushing, weight gain, facial edema, thirst, decreased libido, forgetfulness, decreased appetite, increased appetite, tinnitus, taste distortion, chest discomfort, joint pain, numbness, sensory abnormalities, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This will help retain the drug's effectiveness for a longer time.
Pink round film-coated tablet
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationCandesartan Cilexetil 16mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Green Cross Corp.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
AlboGen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Candesartan Cilexetil 32mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Alvogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 16mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Candesartan Cilexetil 8mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.